A pesar del relevante avance en cuanto al tratamiento de la diabetes en los últimos años, alcanzar los objetivos de control glucémico sigue siendo difícil para un alto porcentaje de personas con diabetes tipo 1. Para lograrlo, se están desarrollando distintas tecnologías, algunas centradas en la medición de la glucosa, mientras que otras se ocupan de la administración de insulina. Los sistemas automatizados de administración de insulina han demostrado ser la tecnología más eficaz para optimizar el control metabólico y podrían ser la clave para alcanzar ampliamente el control glucémico de estos pacientes. Despite significant progress in diabetes treatment in recent years, achieving glycemic control targets remains difficult for a high percentage of people with type 1 diabetes. To achieve this, different technologies are being developed, some focused on glucose measurement, while others deal with insulin delivery. Automated insulin delivery systems have proven to be the most effective technology for optimizing metabolic control and could be the key to achieving glycemic control in these patients.

{"references": ["Vol. 21 N\u00ba2; p\u00e1gs. 66-72. 2019. Foster NC, Beck RW, Miller KM et al. State of type 1 diabetes management and outcomes from the T1D Exchange in 2016-2018. Diabetes Technol Ther. Doi: 10.1089/dia.2018.0384", "Vol. 24 N\u00ba5; p\u00e1gs. 362-371. 2022. Forlenza GP, Lal RA. Current Status and Emerging Options for Automated Insulin Delivery Systems. Diabetes Technol Ther. Doi: 10.1089/dia.2021.0514", "Vol. 387 N\u00ba13; p\u00e1gs. 1228-1229. 2022. Sherr J. Seeking Simpler Solutions with Diabetes Technology. N Engl J Med. Doi: 10.1056/NEJMe2210686", "Vol. 49 N\u00ba4; p\u00e1gs. 667-678. 2020. Sherwood JS, Russell SJ, Putman MS. New and Emerging Technologies in Type 1 Diabetes. Endocrinol Metab Clin North Am. Doi: 10.1016/j.ecl.2020.07.006", "Vol. 12 N\u00ba7; p\u00e1gs. 2019-2033. 2021. Russell SJ, Balliro C, Ekelund M et al. Improvements in Glycemic Control Achieved by Altering the tmax Setting in the iLet\u00ae Bionic Pancreas When Using Fast-Acting Insulin Aspart: A Randomized Trial. Diabetes Ther. Doi: 10.1007/s13300-021-01087-x"]}